January 13, 2025 - Page 3 of 8

TSX News - January 13, 2025

Sernova Announces Voting Results from its Annual and Special General Meeting of Shareholders

LONDON, Ontario and BOSTON, Jan. 13, 2025 (GLOBE NEWSWIRE) — Sernova Corp. (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading […]

TSX News - January 13, 2025

Extendicare Announces Timing of 2024 Fourth Quarter Results and Conference Call

MARKHAM, Ontario, Jan. 13, 2025 (GLOBE NEWSWIRE) — Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it […]

TSX News - January 13, 2025

Update: Profound Medical’s Scheduled Presentation at the 43rd Annual J.P. Morgan Healthcare Conference Moved Up to 9:00am PT on January 16th

TORONTO, Jan. 13, 2025 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device […]

NYSE Companies - January 13, 2025

Perspective Therapeutics Provides Business Updates and Strategic Priorities Ahead of Presentation at 43rd Annual J.P. Morgan Healthcare Conference

Anticipates multiple clinical updates in the next 12-18 months, including further progress from two ongoing clinical programs and initiation of […]

NYSE Companies - January 13, 2025

CPI Aerostructures Awarded Lot 4 Production Contract of Next Generation Jammer Mid-Band Program by Raytheon Technologies

EDGEWOOD, N.Y., Jan. 13, 2025 (GLOBE NEWSWIRE) — CPI Aerostructures, Inc. (“CPI Aero®” or the “Company”) (NYSE American: CVU) announced […]

NYSE Companies - January 13, 2025

Apollo to Acquire Argo Infrastructure Partners

NEW YORK, Jan. 13, 2025 (GLOBE NEWSWIRE) — Apollo (NYSE: APO) today announced that it has entered into an agreement […]

NYSE Companies - January 13, 2025

Calidi Biotherapeutics Announces Presentation of New Data of Systemic Virotherapy RTNova Platform at the AACR Annual Meeting in April 2025

SAN DIEGO, Jan. 13, 2025 (GLOBE NEWSWIRE) — Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing […]